Monika Kulesza
Bialystok, PD 15269, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evaluation of changes in plasma levels of MMP-8, MMP-13, and Thrombospondin 2 in patients with Osgood-Schlatter disease (OSD).
Journal: Frontiers in molecular biosciences
Published: September 11, 2025
Diagnostic Use of Selected Metalloproteinases in Endometrioid Ovarian Cancer.
Journal: Biomedicines
Published: July 29, 2025
Plasma Concentrations of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) as Diagnostic Biomarkers in High-Grade Serous Ovarian Cancer Patients.
Journal: International journal of molecular sciences
Published: April 30, 2025
Plasma Levels of Matrilysins (MMP-7 and MMP-26) and Stromelysins (MMP-3 and MMP-10) in Diagnosis of Endometrial Cancer Patients.
Journal: International journal of molecular sciences
Published: January 28, 2025
Diagnostic Utility of Metalloproteinases from Collagenase Group (MMP-1, MMP-8 and MMP-13) in Biochemical Diagnosis of Ovarian Carcinoma.
Journal: Cancers
Published: October 29, 2024
Title Changes in Plasma Levels of Selected Matrix Metalloproteinases (MMPs) Enzymes in Patients with Osgood-Schlatter Disease (OSD).
Journal: Journal of clinical medicine
Published: August 28, 2024
The Effectiveness of Treating Osgood-Schlatter Disease (OSD) with Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) Depending on the Duration of the Disease.
Journal: Journal of clinical medicine
Published: June 19, 2024
Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer.
Journal: International journal of molecular sciences
Published: April 16, 2024
Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: December 18, 2023
Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases.
Journal: International journal of molecular sciences
Published: October 12, 2023
CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer.
Journal: Cancer management and research
Published: April 09, 2023
Last Updated: 09/26/2026